These metabolic improvements were accompanied by the downregulation of hepatic monoacylglycerol acyltransferase 1 (MGAT1), a gene implicated in insulin resistance and hepatic glucose metabolism [68], further supporting its role in improving glucose homeostasis under insulin-resistant conditions. This evidence concerns the gene INS and Insulin resistance.